High-purity Snap-8 (Acetyl Octapeptide-3) is available from PX1 Research as a lyophilized reference material dedicated strictly to laboratory, in vitro, and preclinical investigation. Every batch undergoes rigorous analytical validation—including RP-HPLC and mass spectrometry—to ensure structural fidelity and experimental reproducibility in biochemical assays.
High-purity Snap-8 (Acetyl Octapeptide-3) is available from PX1 Research as a lyophilized reference material dedicated strictly to laboratory, in vitro, and preclinical investigation. Every batch undergoes rigorous analytical validation—including RP-HPLC and mass spectrometry—to ensure structural fidelity and experimental reproducibility in biochemical assays.
When sourcing Snap-8 for sale for scientific evaluation, obtaining a verified high-purity synthetic peptide is essential for reliable experimental data. Research-grade Snap-8 (Acetyl Octapeptide-3) supplied by PX1 Research is manufactured in the USA under strict Quality Management Systems (QMS), yielding a minimum of 98% purity confirmed through lot-specific reversed-phase high-performance liquid chromatography (RP-HPLC) and mass spectrometry (MS).
Laboratory investigators seeking to study biomolecular signaling, snare-complex attenuation, or dermal extracellular matrix dynamics can purchase Snap-8 peptide in lyophilized format. Designed exclusively for in vitro cell culture, enzymatic assays, and structural binding studies, PX1 Research provides fully transparent lot documentation, analytical certificates of analysis (COAs), and endotoxin testing to support rigorous academic and biotech protocols. Browse our complete inventory of research peptides to support your ongoing experimental designs.
Snap-8 is an elongated analogue of the hexapeptide Acetyl Hexapeptide-8 (Argireline). Structurally, Snap-8 is an octapeptide consisting of the amino acid sequence Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH2. By extending the peptide chain by two amino acid residues compared to its hexapeptide predecessor, researchers observe altered spatial conformation and modified binding kinetics during receptor and protein complex interactions.
The molecular formula of Snap-8 is C41H70N16O16S, with a molecular mass of approximately 1075.14 g/mol. The N-terminal acetylation and C-terminal amidation serve to stabilize the peptide against rapid enzymatic degradation by exopeptidases in aqueous media. In physical form, pure Snap-8 exists as a white to off-white lyophilized cake or powder, which requires proper storage and reconstitution protocols to maintain molecular integrity over extended research timelines.
The primary mechanism of action investigated in relation to Snap-8 centers on its competitive inhibition of the SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex formation. In biological systems, particularly at neuromuscular junctions and neurosecretory cellular pathways, vesicle docking and subsequent neurotransmitter release depend upon the assembly of a stable ternary complex comprising SNAP-25, Syntaxin, and VAMP (Synaptobrevin).
Preclinical in vitro assays suggest that Snap-8 mimics the N-terminal end of SNAP-25, competing with native SNAP-25 for position within the SNARE complex. By destabilizing or destabilizing the assembly of this protein apparatus, Snap-8 inhibits vesicular exocytosis. In neuronal cell culture models, the addition of Snap-8 has been demonstrated to reduce the calcium-dependent release of catecholamines and other signaling molecules, providing a baseline model for evaluating neurotransmitter inhibition and cell-signaling pathways.
Scientific literature surrounding Snap-8 primarily focuses on biochemical binding affinity, cellular cytotoxicity, and comparative efficacy relative to other synthetic signal peptides. In vitro studies utilizing human dermal fibroblasts (HDFs) and neuronal cell lines (such as PC12 cells) have evaluated how synthetic octapeptides alter protein synthesis, cell viability, and vesicle movement without triggering apoptotic pathways.
Data published in preclinical research suggest that Snap-8 exhibits approximately 30% higher potency in inhibiting SNARE complex destabilization than Acetyl Hexapeptide-8 under identical molar concentrations. Furthermore, studies evaluating transdermal transport parameters across reconstructed human epidermis models demonstrate that the molecular charge and hydrophilic profile of Snap-8 necessitate specialized delivery carriers or liposomal formulations when assessing passive tissue penetration. Researchers tracking extracellular matrix interactions often monitor collagen type I transcription and elastogenesis alongside SNARE attenuation.
When designing comparative research protocols in cosmetic biochemistry or cellular signaling, investigators frequently contrast Snap-8 with related peptides in the biomimetic signal class. The table below highlights key functional structural differences among common research compounds available through our platform.
Specifically, while Argireline targets the SNAP-25 domain via a hexapeptide sequence, Snap-8 extends this sequence to eight residues to potentially improve electrostatic interactions with target proteins. In contrast, pentapeptides such as Leuphasyl (Pentapeptide-18) function through an entirely distinct pathway, acting as an enkephalin mimic that targets presynaptic opioid receptors to modulate calcium influx. Meanwhile, copper-binding peptides like GHK-Cu focus on tissue remodeling, gene modulation, and glycosaminoglycan synthesis rather than exocytosis inhibition. Evaluating these compounds side-by-side provides critical insights into complementary mechanisms within extracellular signaling models.
Evaluating a supplier when purchasing Snap-8 for sale requires strict scrutinization of analytical parameters. Substandard peptides containing truncated sequences, residual trifluoroacetic acid (TFA) salts, or heavy metal contaminants can skew in vitro assays, obscure binding data, and induce non-specific cytotoxicity in cell cultures.
PX1 Research enforces stringent quality assurance standards for every lot of synthetic peptide. Our verification matrix includes:
• **RP-HPLC Analysis:** Confirms chemical purity exceeding 98% by separating hydrophobic and hydrophilic impurities, ensuring a clean baseline chromatogram.
• **Mass Spectrometry (MS):** Validates the exact molecular mass (1075.14 Da) and verifies correct sequence identity against reference standards.
• **Endotoxin Testing:** Chromogenic LAL assays ensure endotoxin levels remain below stringent thresholds (<0.01 EU/μg), protecting delicate primary cell lines from immune-mediated interference.
• **USA Manufacturing & ISO 17025 Verification:** All products are synthesized in GMP-compliant facilities within the United States, with independent verification conducted by accredited third-party laboratories. COAs are accessible directly to research entities for full audit traceability.
Maintaining peptide stability is critical to achieving consistent, reproducible results across longitudinal research studies. Snap-8 is supplied as a lyophilized (freeze-dried) powder sealed under inert gas to prevent oxidative degradation during transport and storage.
Upon receipt, lyophilized Snap-8 should be stored in a freezer at -20°C or -80°C, protected from light and moisture. For experimental preparation, researchers should follow established protocols detailed in our peptide reconstitution guide. Reconstitution typically involves solubilizing the peptide in sterile bacteriostatic water or laboratory-grade phosphate-buffered saline (PBS, pH 7.4).
Once reconstituted, aqueous solutions of Snap-8 should be aliquoted into small, single-use working volumes to avoid repeated freeze-thaw cycles, which induce peptide aggregation and cleavage. Reconstituted liquid aliquots remain stable at 2°C to 8°C for up to 30 days, or at -20°C for up to several months. Always allow lyophilized vials to equilibrate to room temperature prior to reconstitution to minimize atmospheric moisture condensation inside the vial.
In analytical laboratories, verifying Snap-8 identity and purity involves specialized high-performance separation and fragmentation techniques. Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC) is conducted utilizing a C18 stationary phase column with a gradient mobile phase consisting of acetonitrile and water supplemented with 0.1% TFA.
Under standard chromatographic conditions, Snap-8 exhibits a sharp, singular retention peak with minimal secondary peaks indicating sequence truncated isomers. Electrospray Ionization Mass Spectrometry (ESI-MS) further yields distinct single- and double-charged ion peaks corresponding to the calculated molecular weight of the acetylated octapeptide. Reviewing these analytical profiles via our dedicated research hub allows scientists to verify lot consistency prior to initiating high-throughput screening assays.
PX1 Research is dedicated to supplying verified research chemicals to academic institutions, biotechnology companies, and independent laboratories across the United States. We recognize that empirical integrity depends directly upon the quality of raw materials used at the bench.
By maintaining dual distribution facilities in California and Arizona, PX1 Research provides rapid same-day dispatch for orders placed Monday through Friday. Every product listing—including bulk purchase options available through our wholesale program—is backed by transparent batch tracking, comprehensive COAs, and rigorous cold-chain packaging options. When your research requires uncompromised chemical fidelity, PX1 Research delivers reliable reagents engineered to advance scientific discovery.
What is the purity level of Snap-8 available from PX1 Research?
PX1 Research supplies Snap-8 (Acetyl Octapeptide-3) at a minimum purity of 98%, verified by lot-specific RP-HPLC and mass spectrometry testing.
What is the primary mechanism of Snap-8 studied in preclinical research?
Snap-8 is studied for its ability to competitively inhibit SNARE complex formation by mimicking the N-terminal end of SNAP-25, thereby reducing neurotransmitter exocytosis in cellular models.
Is Snap-8 approved for human consumption or cosmetic application?
No. Snap-8 supplied by PX1 Research is strictly designated for laboratory research, in vitro experiments, and preclinical investigation. It is not intended for human or animal therapeutic, cosmetic, or diagnostic use.
How should lyophilized Snap-8 be stored upon delivery?
Lyophilized Snap-8 should be stored at -20°C or -80°C in a dry environment protected from light. Under these conditions, the un-reconstituted peptide remains stable for up to 24 months.
What solvent is recommended for reconstituting Snap-8 for in vitro assays?
Snap-8 readily dissolves in sterile laboratory-grade water or phosphate-buffered saline (PBS, pH 7.4). Solvent selection depends on the specific requirements of the downstream cellular or enzymatic assay.
Does PX1 Research provide Certificates of Analysis (COAs) with Snap-8 orders?
Yes. Every lot of Snap-8 includes a downloadable, batch-specific COA detailing RP-HPLC purity chromatograms, mass spectrometry results, and endotoxin assay data.
How does Snap-8 differ structurally from Argireline?
Snap-8 (Acetyl Octapeptide-3) contains an eight-amino-acid sequence, extending the six-amino-acid sequence of Argireline (Acetyl Hexapeptide-8). Preclinical studies evaluate whether this structural extension alters binding affinity to the SNARE complex.
Where are PX1 Research peptides manufactured and shipped from?
All PX1 Research compounds are manufactured in USA-based, ISO 17025 accredited and GMP-compliant facilities, and fulfilled from our distribution hubs in California and Arizona.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.